Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors-Reference-Cited by-同舟云学术

Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors

Published:2023-02 Issue:2 Volume:21 Page:406-414.e7
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Rodriguez-Duque Juan Carlos,Calleja José Luis,Iruzubieta Paula,Hernández-Conde Marta,Rivas-Rivas Coral,Vera María Isabel,Garcia Maria Jose,Pascual Marta,Castro Beatriz,García-Blanco Agustín,García-Nieto Enrique,Olmo Soraya Curiel-del,Cagigal María Luisa,Lopez-Montejo Lorena,Fernández-Lamas Tatiana,Rasines Laura,Fortea José Ignacio,Vaque José Pedro,Frias Yza,Rivero Montserrat,Arias-Loste María Teresa,Crespo Javier

Funder

ISCIII

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Liver function test abnormalities in patients with inflammatory bowel diseases: a hospital-based survey;Cappello;Clin Med Insights Gastroenterol,2014

2. Comorbidity in inflammatory bowel disease;Román;World J Gastroenterol,2011

3. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: beyond the natural history;Magrì;World J Gastroenterol,2019

4. Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis;Yamamoto-Furusho;Ann Hepatol,2010

5. Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients;Gisbert;Inflamm Bowel Dis,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases;Seminars in Immunology;2024-02

2. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease;European Journal of Internal Medicine;2024-02

3. Metabolic Dysfunction–Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Proposed Stepwise Approach;Clinical Gastroenterology and Hepatology;2024-02

4. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores;BMC Gastroenterology;2023-12-13

5. New Insights into Nutrition and Gut–Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease;Nutrients;2023-11-25